5 unknown. 5 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Unknown 5 |
Follow Anticoagulant: new trials by email Literature Review of Anticoagulant trials Research Report on Anticoagulant
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of the Pharmacodynamics of a Heparin With Its Biological Comparator, Subcutaneous Administration Heparin - Anticoagulant | Phase 1 | Unknown | Blau Farmaceutica S.A. | 68 | 2023-06-01 | 2023-03-29 |
| Evaluation of the Pharmacodynamics of a Heparin With Its Biological Comparator, Intravenous Administration Heparin - Anticoagulant | Phase 1 | Unknown | Blau Farmaceutica S.A. | 68 | 2023-06-01 | 2023-03-29 |
| A Clinical Study to Evaluate the Safety and Pharmacokinetics of CKD-344 in Healthy Volunteers Lixiana(D006), CKD-344 - Anticoagulant | Phase 1 | Unknown | Chong Kun Dang Pharmaceutical | 60 | 2021-04-27 | 2021-04-30 |
| A Single Dose Bioequivalence Study of WD-1602 Versus Pradaxa® in Healthy Subjects Under Fed Condition WD-1602, Pradaxa® - Anticoagulant | Phase 1 | Unknown | Hong Kong WD Pharmaceutical Co., Limited | 20 | 2021-01-06 | 2020-11-02 |
| A Clinical Study to Evaluate the Safety and Pharmacokinetics of CKD-344 Lixiana(D006), CKD-344 - Anticoagulant | Phase 1 | Unknown | Chong Kun Dang Pharmaceutical | 50 | 2020-11-13 | 2020-12-17 |
Drug Evaluation (2) · Heparin (2) · Dabigatran (1)
Blau Farmaceutica S.A. (2) · Chong Kun Dang Pharmaceutical (2) · Hong Kong WD Pharmaceutical Co., Limited (1)
South Korea (2)
Yook-Hwan Noh (2)